Nishadil
Signup Signin
Delhi | 25°C (windy)
A New Frontier in Breast Cancer: Enhertu Unveils Remarkable Promise for Early-Stage HER2-Low Patients

A New Frontier in Breast Cancer: Enhertu Unveils Remarkable Promise for Early-Stage HER2-Low Patients
Enhertu's Triumph: AstraZeneca and Daiichi Sankyo Unveil Pivotal Phase 3 Data, Reshaping Cancer Care

Enhertu's Triumph: AstraZeneca and Daiichi Sankyo Unveil Pivotal Phase 3 Data, Reshaping Cancer Care
A New Dawn for Early Breast Cancer: Enhertu's Groundbreaking Impact Revealed at ESMO 2025

A New Dawn for Early Breast Cancer: Enhertu's Groundbreaking Impact Revealed at ESMO 2025
A New Horizon for Breast Cancer: Enhertu Shows Groundbreaking Survival Benefit in HER2-low Metastatic Patients

A New Horizon for Breast Cancer: Enhertu Shows Groundbreaking Survival Benefit in HER2-low Metastatic Patients
Load more..